Corvus Pharmaceuticals, Inc. (CRVS)

NASDAQ: CRVS · IEX Real-Time Price · USD
0.960
+0.044 (4.80%)
At close: Aug 8, 2022 4:00 PM
0.900
-0.060 (-6.250%)
After-hours: Aug 8, 2022 7:45 PM EDT

Income Statement (Quarterly)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Selling, General & Admin
2.312.022.062.183.252.693.232.913.112.522.522.962.892.782.782.542.542.52.212.792.722.122.771.711.031.20.610.330.29
Research & Development
5.14.796.999.118.237.196.627.8610.168.92910.649.428.398.379.7212.19.6910.7312.3913.59.137.717.125.44.912.512.011.92
Operating Expenses
7.416.819.0511.2911.489.889.8510.7713.2711.4411.5113.612.3111.1711.1512.2614.6412.1912.9415.1716.2211.2510.488.836.436.13.122.332.21
Operating Income
-7.41-6.81-9.05-11.29-11.48-9.88-9.85-10.77-13.27-11.44-11.51-13.6-12.31-11.17-11.15-12.26-14.64-12.19-12.94-15.17-16.22-11.25-10.48-8.83-6.43-6.1-3.12-2.33-2.21
Other Expense / Income
0.882.431.630.460.1-37.23-0.05-0.16-0.33-0.39-0.51-0.62-0.66-0.66-0.65-0.63-0.34-0.26-0.23-0.19-0.18-0.16-0.18-0.18-0.08-0.070.0317.9-0.3
Pretax Income
-8.3-9.24-10.67-11.75-11.5827.35-9.8-10.61-12.94-11.05-11-12.98-11.64-10.51-10.5-11.63-14.3-11.93-12.72-14.98-16.04-11.09-10.3-8.65-6.35-6.04-3.15-20.23-1.91
Net Income
-8.3-9.24-10.67-11.75-11.5827.35-9.8-10.61-12.94-11.05-11-12.98-11.64-10.51-10.5-11.63-14.3-11.93-12.72-14.98-16.04-11.09-10.3-8.65-6.35-6.04-3.15-20.23-1.91
Net Income Common
-8.3-9.24-10.67-11.75-11.5827.35-9.8-10.61-12.94-11.05-11-12.98-11.64-10.51-10.5-11.63-14.3-11.93-12.72-14.98-16.04-11.09-10.3-8.65-6.35-6.04-3.15-20.23-1.91
Shares Outstanding (Basic)
47474442353030292929292929292929232121202015202010000
Shares Outstanding (Diluted)
47474442353030292929292929292929232121202015202010000
Shares Change
34.88%57.14%48.97%43.56%17.35%0.86%0.38%0.41%0.41%0.29%1.04%1.14%29.72%41.81%41.88%41.87%10.96%34.06%1.57%2.34%1629.59%4027.48%5005.61%5662.98%295.98%----
EPS (Basic)
-0.18-0.19-0.24-0.28-0.340.93-0.33-0.36-0.44-0.38-0.37-0.44-0.40-0.36-0.36-0.40-0.63-0.58-0.62-0.73-0.79-0.53-0.51-0.43-5.39-10.88-7.97-58.42-6.44
EPS (Diluted)
-0.18-0.19-0.24-0.28-0.340.93-0.33-0.36-0.44-0.38-0.37-0.44-0.40-0.36-0.36-0.40-0.63-0.58-0.62-0.73-0.79-0.53-0.51-0.43-5.39-10.88-7.97-58.42-6.44
Free Cash Flow Per Share
-0.14-0.15-0.19-0.30-0.26-0.28-0.27-0.32-0.32-0.29-0.36-0.31-0.31-0.29-0.38-0.38-0.49-0.53-0.53-0.58-0.63-0.65-0.34-0.35-5.31-12.85-8.49-6.55-8.91
EBITDA
-8.21-9.14-10.57-11.63-11.4427.49-9.65-10.45-12.75-10.86-10.82-12.79-11.46-10.33-10.27-11.41-14.08-11.71-12.51-14.77-15.83-10.9-10.14-8.5-6.24-5.98-3.1-20.2-1.91
Depreciation & Amortization
0.090.090.110.120.140.140.150.160.180.190.190.190.190.180.230.220.220.220.210.210.20.190.160.140.110.060.060.040
EBIT
-8.3-9.24-10.67-11.75-11.5827.35-9.8-10.61-12.94-11.05-11-12.98-11.64-10.51-10.5-11.63-14.3-11.93-12.72-14.98-16.04-11.09-10.3-8.65-6.35-6.04-3.15-20.23-1.91
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).